Telo Genomics Corp. (TSXV:TELO)
Canada · Delayed Price · Currency is CAD 0.0700
+0.0200 (40.00%)
Oct 9, 2026, 1:48 PM EST
Telo Genomics Market Cap
Telo Genomics has a market cap or net worth of CAD 7.03 million as of October 9, 2026. It is the 45,061st most valuable company in the world and the 1,784th biggest in Canada. Its market cap has increased by 7.69% in one year.
Market Cap
7.03M
Enterprise Value
7.37M
Revenue
n/a
Global Rank
Country Rank
#1,784 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since September 13, 2016, Telo Genomics's market cap has decreased from 23.22M to 7.03M, a decrease of -69.73%. That is a compound annual growth rate of -11.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 7.03M | 40.00% |
| Dec 31, 2025 | 5.02M | -61.38% |
| Dec 30, 2024 | 13.00M | -8.83% |
| Dec 29, 2023 | 14.26M | -32.39% |
| Dec 30, 2022 | 21.10M | -13.41% |
| Dec 31, 2021 | 24.36M | 87.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.44B |
| Curaleaf Holdings | 3.72B |
| Extendicare | 2.64B |
| Sienna Senior Living | 2.14B |
| Mercanto Holdings | 5.68M |
| PharmaTher Holdings | 5.46M |
| Diagnamed Holdings | 5.26M |
| MYND Life Sciences | 5.22M |